Acadian Asset Management’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-525,628
| Closed | -$2.58M | – | 1919 |
|
|
2021
Q3 | $2.58M | Sell |
525,628
-67,637
| -11% | -$332K | 0.01% | 619 |
|
|
2021
Q2 | $3.13M | Buy |
593,265
+285,565
| +93% | +$1.51M | 0.01% | 585 |
|
|
2021
Q1 | $1.48M | Buy |
307,700
+60,422
| +24% | +$290K | 0.01% | 824 |
|
|
2020
Q4 | $1.07M | Buy |
247,278
+22,736
| +10% | +$98.5K | ﹤0.01% | 963 |
|
|
2020
Q3 | $925K | Buy |
224,542
+102,283
| +84% | +$421K | ﹤0.01% | 937 |
|
|
2020
Q2 | $313K | Buy |
122,259
+104,076
| +572% | +$266K | ﹤0.01% | 1345 |
|
|
2020
Q1 | $53K | Buy |
+18,183
| New | +$53K | ﹤0.01% | 1493 |
|
|
2016
Q1 | – | Sell |
-30,034
| Closed | -$850K | – | 1532 |
|
|
2015
Q4 | $850K | Sell |
30,034
-75,005
| -71% | -$2.12M | ﹤0.01% | 712 |
|
|
2015
Q3 | $1.76M | Sell |
105,039
-213,574
| -67% | -$3.58M | 0.01% | 575 |
|
|
2015
Q2 | $8.35M | Sell |
318,613
-61,707
| -16% | -$1.62M | 0.04% | 318 |
|
|
2015
Q1 | $6.66M | Buy |
380,320
+192,007
| +102% | +$3.36M | 0.03% | 345 |
|
|
2014
Q4 | $3.27M | Buy |
188,313
+181,136
| +2,524% | +$3.15M | 0.01% | 468 |
|
|
2014
Q3 | $134K | Buy |
+7,177
| New | +$134K | ﹤0.01% | 806 |
|